← Back to Patent Explorer
US4818749A Expired / Lapsed US ⏱️ 0.0 years remaining

Carboxyalkyl dipeptides and medical use thereof in treating hypertension and congestive heart failure

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1987-11-04
•
Granted: 1989-04-04
•
Expires: 2007-11-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to carboxyalkyl dipeptides which are inhibitors of angiotensin-converting enzyme and are useful as antihypertensive agents and in the treatment of congestive heart failure. The compounds of the present invention are compounds of the formulae <IMAGE> I and <IMAGE> II and the pharmaceutically acceptable salts thereof, wherein R and R6 are the same or different and are hydroxy or lower alkoxy; R1 is benzyloxylower alkyl or benzylthiolower alkyl; R2 is benzylthiomethyl, 2-phyenylethylthiomethyl, napthylmethylthiomethyl, methylbenzylthiomethyl, 2-(carboxyphenyl)ethyl or 2-(alkoxycarbonylphenyl)ethyl) and R3 is hydrogen, lower alkyl or aminolower alkyl.

Inventors

  • 👤 Elijah H. Gold
  • 👤 Bernard R. Neustadt
  • 👤 Elizabeth M. Smith

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 00:51
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/02; C07K5/022; C07K5/0222; A; A61; A61P; A61P43/00; A61P9/00; A61P9/12; A61K; A61K38/00

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 49 words
A compound represented by the formula ##STR12## and the pharmaceutically acceptable salts thereof, wherein R and R 6 are the same or different and are hydroxy or lower alkoxy; R 2 is benzylthiomethyl, 2-phenylethylthiomethyl, naphthylmethylthiomethyl, methylbenzylthiomethyl, carboxyphenylethyl or alkoxycarbonylphenylethyl; and R 3 is hydrogen, lower alkyl or aminolower alkyl.
Claim 2
Dependent Claim 49 words
A compound represented by the formula ##STR12## and the pharmaceutically acceptable salts thereof, wherein R and R 6 are the same or different and are hydroxy or lower alkoxy; R 2 is benzylthiomethyl, 2-phenylethylthiomethyl, naphthylmethylthiomethyl, methylbenzylthiomethyl, carboxyphenylethyl or alkoxycarbonylphenylethyl; and R 3 is hydrogen, lower alkyl or aminolower alkyl.
Claim 3
Dependent Claim 10 words
A compound of claim 1 wherein R is lower alkoxy.
Claim 4
Dependent Claim 9 words
A compound of claim 1 wherein R is ethoxy.
Claim 5
Dependent Claim 10 words
A compound of claim 1 wherein R 6 is hydroxy.
Claim 6
Dependent Claim 11 words
A compound of claim 1 wherein R 3 is lower alkyl.
Claim 7
Dependent Claim 10 words
A compound of claim 1 wherein R 3 is methyl.
Claim 8
Dependent Claim 10 words
A compound of claim 1 wherein R 2 is benzylthiomethyl.
Claim 9
Dependent Claim 10 words
A compound of claim 1 wherein R 2 is 2-phenylethylthiomethyl.
Claim 10
Dependent Claim 10 words
A compound of claim 1 wherein R 2 is naphthylmethylthiomethyl.
Claim 11
Dependent Claim 10 words
A compound of claim 1 wherein R 2 is methylbenzylthiomethyl.
Claim 12
Dependent Claim 10 words
A compound of claim 1 wherein R 2 is carboxyphenylethyl.
Claim 13
Dependent Claim 10 words
A compound of claim 1 wherein R 2 is alkoxycarbonylphenylethyl.
Claim 14
Dependent Claim 10 words
A compound of claim 12 wherein R 2 is ethoxycarbonylphenylethyl.
Claim 15
Dependent Claim 30 words
A compound of claim 1 wherein R is lower alkoxy, R 6 is hydroxy, R 3 is lower alkyl, and R 2 is benzylthiomethyl, 2-phenylethylthiomethyl, naphthylmethylthiomethyl, methylbenzylthiomethyl, carboxyphenylethyl or ethoxycarbonylphenylethyl.
Claim 16
Dependent Claim 14 words
A compound of claim 14 wherein R is ethoxy and R 3 is methyl.
Claim 17
Dependent Claim 17 words
A compound of claim 14 selected from 1-[N-[1(R)-ethoxycarbonyl-2-(4-methylbenzylthio)ethyl]-(R,S)-alanyl]-cis,syn-perhydroindole-2(S)-carboxylic acid; 1-[N-[1(S)-ethoxycarbonyl-3-(4-ethoxycarbonylphenyl)propyl]-(S)-alanyl]-cis,syn-perhydroindole-2(S)carboxylic acid; 1-[N-[1(R)-ethoxycarbonyl-2-(benzylthio)ethyl]-(R,S)-alanyl]-cis,syn-perhydroindole-2(S)-carboxylic acid; 1-[N-[1(R)-ethoxycarbonyl-2-(phenylthio)ethyl]-(S)-alanyl]-cis,syn-perhydroindole-2(S)-carboxylic acid; 1-[N-[1(R)-ethoxycarbonyl-2-(2-naphthylmethylthio)ethyl]-(S)-alanyl]-cis,syn-perhydroindole-2(S)-carboxylic acid.
Claim 18
Dependent Claim 14 words
A compound of claim 11 wherein R is hydroxy and R 3 is methyl.
Claim 19
Dependent Claim 9 words
A compound of claim 17 which is 1-[N-(1(S)-carboxy-3-(4-carboxyphenyl)propyl]-(S)-alanyl]-cis,syn-perhydroindole-2(S)-carboxylic acid.
Claim 20
Dependent Claim 21 words
An antihypertensive pharmaceutical composition comprising an antihypertensive effective amount of a compound of claim 1, together with a pharmaceutically acceptable carrier.
Claim 21
Dependent Claim 22 words
A method for reducing blood pressure in a hypertensive mammal which comprises administering to such a mammal a composition of claim 19.
Claim 22
Dependent Claim 35 words
A method of treating congestive heart failure in a mammal in need of such treatment comprising administering to such a mammal an amount of a compound of claim 1 effective in treating congestive heart failure.

References Cited (Backward Citations)

US4374829A Cited
US4508729A Cited
EP0049658A1 Cited
US4350704A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-04-03 1992-10-03 1993-04-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-04-03 1996-10-03 1997-04-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-04-03 2000-10-03 2001-04-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag